English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1with about 5 million of them living in South Africa (SA). The World Health Organization estimated that 4.7 million people living in sub-Saharan Africa urgently needed antiretroviral therapy (ART). In that year SA implemented prescribed minimum benefits (PMBs) for HIV/AIDS in the private health care sector. 2 Despite the increased availability and affordability of ART in SA, only 60 000 people were receiving ART through medical aid schemes by mid-2005. 3 Antiretrovirals (ARVs) have transformed HIV/AIDS into a chronic disorder that can be managed effectively. The right of all HIVinfected adults and children to receive standard care is endorsed by the SA HIV Clinicians Society (SAHIVCS), 4 with ART guidelines recommending different combinations. The rapid approval of new drugs resulted in an increased risk of prescribing errors, dispensing of incorrect dosages/dose frequencies, and incorrect reporting of drugs by the patient to the prescribers, 5 all leading to treatment failure. Drug-drug interactions (DDIs) are an under-recognised consequence of medication prescription errors, resulting in significant health care costs. 6 Since DDIs determine positive and negative consequences of treatment for HIV-infected patients, recommendations to avoid some drug combinations and to adjust dosages of some co-administered drugs were formulated by both the SAHIVCS 4

Antiretroviral prescriptions with potential drug-drug interactions from general practitioners and specialists